Journal
BASIC AND CLINICAL NEUROSCIENCE
Volume 13, Issue 2, Pages 207-214Publisher
IRAN UNIV MEDICAL SCIENCES
DOI: 10.32598/bcn.2021.35.4
Keywords
Methylprednisolone; Neural stem cells; proliferation; survival; migration
Categories
Funding
- Shiraz University of Medical sciences [10750-74-01-94]
Ask authors/readers for more resources
This study revealed that the combination of methylprednisolone (MP) and neural stem/progenitor cells (NS/PCs) has adverse effects on the survival and proliferation of NS/PCs, therefore, this combination is not recommended.
Introduction: To address the question whether combination of methylprednisolone (MP) as an anti-inflammatory drug used in neurodegenerative diseases and neural stem/progenitor cells (NS/PCs) is safe, the present study was designed. Methods: Embryonic rat NS/PCs were exposed to different concentrations of MP and survival by MTT assay, proliferation by analyzing the number and diameter of neurospheres and the migration of the cells by neurosphere assay were evaluated. Results: The viability of NS/PCs reduced following exposure to 10, 15 and 20 mu g/ml of MP. In addition, although the number of neurospheres didn't change, exposure to different concentrations of MP resulted in formation of smaller neurospheres. Despite these undesirable effects, the highest concentration of MP (20 mu g/ml) increased the migration capacity of the NS/PCs. Conclusion: The combination of MP and NS/PCs is not recommended due to the adverse effects of MP on survival and proliferation of NS/PCs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available